BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11895209)

  • 21. Two rare TSH receptor amino acid substitutions in toxic thyroid adenomas.
    Nanba K; Usui T; Minamiguchi S; Mori Y; Watanabe Y; Honda K; Asato R; Nakao K; Kawashima ST; Yuno A; Tamanaha T; Tagami T; Naruse M; Akiyama Y; Shimatsu A
    Endocr J; 2012; 59(1):13-9. PubMed ID: 22001338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lower incidence of postpartum thyrotoxicosis in women with Graves disease treated by radioiodine therapy than by subtotal thyroidectomy or with antithyroid drugs.
    Yoshihara A; Noh JY; Watanabe N; Iwaku K; Kobayashi S; Suzuki M; Ohye H; Matsumoto M; Kunii Y; Mukasa K; Ito K
    Clin Nucl Med; 2014 Apr; 39(4):326-9. PubMed ID: 24566408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coexistence of an autonomously functioning thyroid nodule in a patient with Graves' disease: an unusual presentation of Marine-Lenhart syndrome.
    Nishikawa M; Yoshimura M; Yoshikawa N; Toyoda N; Yonemoto T; Ogawa Y; Mori S; Tabata S; Tokoro T; Sakaguchi N; Inada M
    Endocr J; 1997 Aug; 44(4):571-4. PubMed ID: 9447292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An uncommon case of Marine-Lenhart syndrome.
    Giuffrida G; Giovinazzo S; Certo R; Vicchio TM; Baldari S; Campennì A; Ruggeri RM
    Arq Bras Endocrinol Metabol; 2014 Jun; 58(4):398-401. PubMed ID: 24936736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid hormones, their carrier proteins, and thyroid antibodies in the pleural effusion of two patients with graves' disease-induced thyrotoxicosis.
    Kinoshita H; Yasuda M; Kaneko S; Usui R; Inoshita S; Furumoto Y; Maruyama Y; Susa K; Suenaga M; Fujita H; Tomiyama J; Yakushiji F
    Endocr Res; 2010; 35(4):183-7. PubMed ID: 20868289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The hyperfunctioning thyroid nodule.
    Morton WM; Runyan JW
    South Med J; 1969 Sep; 62(9):1036-41. PubMed ID: 5820302
    [No Abstract]   [Full Text] [Related]  

  • 27. Graves' disease triggered by autoinfarction of an autonomously functioning thyroid adenoma.
    Gallegos E; Meier DA; Garcia M
    J Nucl Med; 1997 Feb; 38(2):260-2. PubMed ID: 9025752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid cancer yield in patients with Graves' disease.
    Stocker DJ; Burch HB
    Minerva Endocrinol; 2003 Sep; 28(3):205-12. PubMed ID: 14605602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Graves' disease and concurrent thyroid carcinoma. The importance of thyroid scintigraphy in Graves' disease.
    Joseph UA; Jhingran SG
    Clin Nucl Med; 1995 May; 20(5):416-8. PubMed ID: 7628144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coexistent thyroid nodules in patients with graves' disease: What is the frequency and the risk of malignancy?
    Shi HH; McHenry CR
    Am J Surg; 2018 Nov; 216(5):980-984. PubMed ID: 30049435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of Graves' disease after surgical treatment for thyroid nodules: report of four cases.
    Kasuga Y; Kobayashi S; Fujimori M; Shingu K; Hama Y; Ito K; Amano J
    Endocr J; 1997 Aug; 44(4):567-70. PubMed ID: 9447291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Metabolic radiotherapy of hyperthyroidism].
    Salvatore M; Brunetti A
    Ann Ital Chir; 1989; 60(5):367-71. PubMed ID: 2699388
    [No Abstract]   [Full Text] [Related]  

  • 33. Thyrotropin-producing pituitary adenoma simultaneously existing with Graves' disease: a case report.
    Arai N; Inaba M; Ichijyo T; Kagami H; Mine Y
    J Med Case Rep; 2017 Jan; 11(1):9. PubMed ID: 28061802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Review and Update on the Management of Thyroid Storm.
    De Almeida R; McCalmon S; Cabandugama PK
    Mo Med; 2022; 119(4):366-371. PubMed ID: 36118802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicentre study of thyroid nodules in patients with Graves' disease.
    Kraimps JL; Bouin-Pineau MH; Mathonnet M; De Calan L; Ronceray J; Visset J; Marechaud R; Barbier J
    Br J Surg; 2000 Aug; 87(8):1111-3. PubMed ID: 10931060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The management of thyrotoxicosis: a schematic approach].
    Papi G; Carapezzi C; Corsello SM
    Minerva Endocrinol; 2002 Jun; 27(2):119-26. PubMed ID: 11961503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Basedow's disease and thyroid nodules. A common association].
    Kraimps JL; Bouin-Pineau MH; Maréchaud R; Barbier J
    Ann Chir; 1998; 52(5):449-51. PubMed ID: 9752485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Graves' disease].
    Izumi Y; Amino N
    Ryoikibetsu Shokogun Shirizu; 2000; (31):92-5. PubMed ID: 11269198
    [No Abstract]   [Full Text] [Related]  

  • 39. Can cytomorphology differentiate between benign nodules and tumors arising in Graves' disease?
    Anderson SR; Mandel S; LiVolsi VA; Gupta PK; Baloch ZW
    Diagn Cytopathol; 2004 Jul; 31(1):64-7. PubMed ID: 15236269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Encapsulated insular carcinoma of the thyroid arising in graves' disease: report of a case and review of the literature.
    Foroughi F; Saadat N; Salehian MT
    Int J Surg Pathol; 2012 Dec; 20(6):636-9. PubMed ID: 22689614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.